Log in to save to my catalogue

Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinic...

Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinic...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2446264733

Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection

About this item

Full title

Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection

Publisher

United States: Public Library of Science

Journal title

PloS one, 2020-09, Vol.15 (9), p.e0239799

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

To investigate the association between serum 25-hydroxyvitamin D levels and its effect on adverse clinical outcomes, and parameters of immune function and mortality due to a SARS-CoV-2 infection.
The hospital data of 235 patients infected with COVID-19 were analyzed.
Based on CDC criteria, among our study patients, 74% had severe COVID-19 inf...

Alternative Titles

Full title

Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2446264733

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2446264733

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0239799

How to access this item